BiotechTube
Home/Thymmune Therapeutics/Stan Wang, MD, PhD
SW

Stan Wang, MD, PhD

CEO & Founder

Thymmune Therapeutics

Therapeutic Areas

ImmunodeficienciesTransplant MedicineAutoimmune DisordersAging

Thymmune Therapeutics Pipeline

DrugIndicationPhase
Platform-derived thymic cell therapyImmune dysfunction in aging and disease (Immunodeficiencies, Transplant-related, Autoimmune)Pre-clinical

Leadership Team at Thymmune Therapeutics

BL
Bing Lim, MD, PhD
Chief Scientific Officer
MJ
Manish Jain
Chief Technology Officer
View full Thymmune Therapeutics profile